Overview

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether 68Gallium PSMA-PET/CT scans are an effective way to detect sites of cancer in people with metastatic bladder cancer. The study researchers want to learn if a 68Gallium PSMA PET/CT scan will work better, the same, or not as well as the PET/CT scans doctors usually use for imaging bladder cancer (FDG-PET/CT scan).
Phase:
Phase 1
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center